Semi-annual Report for 2026
Filed with SSE · · 196 pages · Chinese
Beijing Balance Medical Technology Co. Ltd. on 6ix
Earlier from Beijing Balance Medical Technology
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on the Voluntary Disclosure of the Approval for Registration of the Subsidiary's Cross-Linked Collagen Implant Product (Collagen Fiber Filler-II)
- Announcement on Canceling Certain Restricted Stock Granted but Not Yet Vested for 2020
- Announcement on the Opening of an Additional Securities Account for Share Repurchase
Later from Beijing Balance Medical Technology
- Announcement on Voluntary Disclosure of the Failure to Obtain Approval for the Registration Application for Ophthalmic Surgical Biological Patch
- Announcement on Voluntary Disclosure of the Aortic Root Enlargement Patch Entering the Special Review Procedure for Innovative Medical Devices
- Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product, Valved Patch for Complex Congenital Heart Disease
- Announcement on Implementation Results of Share Repurchase
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product Transcatheter Pulmonary Valve System
Follow Beijing Balance Medical Technology into a list and get an email when it puts out news.
Follow Beijing Balance Medical Technology